Shares of INVO Bioscience, Inc. (INVO) surged on a deal to buy NAYA Biosciences in an all-stock deal.
INVO is currently trading at $2.8400, up $2.3000 or 425.9259%, on a volume of 33.7 million shares, above average volume of 228 thousand, on the Nasdaq. The stock began trading at $1.4800 after closing Friday at $0.5400. The stock has traded between $0.5000 and $25.4000 in the past 52-week period.
INVO Bioscience agreed to acquire NAYA Biosciences in an all-stock transaction. As per the terms of the deal, NAYA Biosciences' shareholders will receive 7.3333 shares of INVO for each share of NAYA Biosciences at closing, for a total of about 18.15 million shares of INVO.
In connection with the Merger, INVO will issue to NAYA more than 80 percent (of its common stock, effectively resulting in a change of control.
Following the closing of the Merger, the combined company is expected to operate under the name "NAYA Biosciences". Daniel Teper, currently Chairman & CEO of NAYA Biosciences, will be named Chairman & chief executive officer of the combined company.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.